 | Brainstorm Cell Therapeutics In | |||
| NCM : BCLI || Location: United States | ||||
$0.53-0.02 (-3.27%) |
0.27 M | 0.52 - 0.56 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 1.992 M |
| March 28, 2024 | 1.343 M |
| March 15, 2024 | 0.850 M |
| Feb. 29, 2024 | 1.067 M |
| Feb. 15, 2024 | 1.235 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -0.14 | -0.14 | 1.96% |
| 06/30/2023 | -0.15 | -0.27 | -76.47% |
| 03/31/2023 | -0.17 | -0.14 | 16.82% |
| 12/31/2022 | -0.15 | -0.13 | 12.10% |
| 09/30/2022 | -0.18 | -0.19 | -5.60% |
BCLI Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 68.342M | Shares Float | 61.064M |
| Short Float | 1.992M | Market Cap | 36.90M |
| Institution ownership | 5.99% | Insider ownership | 13.161% |
| Earnings Date | 05/10/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.40 | Forward EPS | -0.28 |